Byron Lam, MD, and Benjamin Bakall, MD, PhD, discuss what an FDA approval of tinlarebant could mean for the Stargardt disease ...
Host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Flaxel and Dr. Rudnick about how a home monitoring device could ...
COMO (NCT07449936) and CAPRI (NCT07449923), the two global Phase 3 trials of EYP-1901 vorolanib intravitreal insert (DURAVYU) ...
Since I started offering robotic laser cataract surgery, I have always been straightforward with patients, but it surprised me how much they lit up when they heard me say during a surgical ...
Vezocolmitide (ST-100; Stuart Therapeutics) is a collagen mimetic peptide (CMP) therapy designed to seek out and repair ...
Woźniak, MD, PhD, discusses his real-world evidence study on a dry eye lubricating drop, including its effects on tear film ...
Cataract surgery often addresses one eye at a time, doubling patient travel and the use of resources, further elevating ...
In the latest episode of The Wills Retina Report, Dr. Regillo and Dr. Hsu discuss why sustained delivery with the port ...
Noha Ekdawi, MD, FAAP, explains why pediatric myopia demands individualized, progression-based management—detailing how they sequence spectacle defocus lenses, low-dose atropine, and specialty ...
In this episode of NeuroOp Guru in collaboration with Ophthalmology Times, host Andrew G. Lee, MD, is joined by Drew Carey, ...
Robin A. Vora, MD, a retina specialist at Kaiser Permanente Oakland Medical Center, told Modern Retina that misdiagnosis of ...
Artelo Biosciences has enrolled the first patient in the phase 2 DREAM study, evaluating the company’s orally administered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results